Pablo M Casillas-Espinosa1, Pedro Andrade2, Cesar Santana-Gomez3, Tomi Paananen2, Gregory Smith4, Idrish Ali1, Robert Ciszek2, Xavier Ekolle Ndode-Ekane2, Rhys D Brady1, Jussi Tohka2, Matthew R Hudson1, Piero Perucca5, Emma L Braine1, Riikka Immonen2, Noora Puhakka2, Sandy R Shultz1, Nigel C Jones1, Richard J Staba3, Asla Pitkänen2, Terence J O'Brien6. 1. The Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Australia. 2. A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland. 3. Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States. 4. Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States. 5. The Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Australia; Department of Neurology, The Alfred Hospital, Commercial Road, Melbourne, Victoria, 3004, Australia; Department of Neurology, The Royal Melbourne Hospital, Grattan Street, Parkville, Victoria, 3050, Australia. 6. The Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Australia; Department of Neurology, The Alfred Hospital, Commercial Road, Melbourne, Victoria, 3004, Australia; Department of Neurology, The Royal Melbourne Hospital, Grattan Street, Parkville, Victoria, 3050, Australia. Electronic address: Terence.OBrien@monash.edu.
Abstract
RATIONALE: The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) Centre without walls is an NIH funded multicenter consortium. One of EpiBioS4Rx projects is a preclinical post-traumatic epileptogenesis biomarker study that involves three study sites: The University of Eastern Finland, Monash University (Melbourne) and the University of California Los Angeles. Our objective is to create a platform for evaluating biomarkers and testing new antiepileptogenic treatments for post-traumatic epilepsy (PTE) using the lateral fluid percussion injury (FPI) model in rats. As only 30-50% of rats with severe lateral FPI develop PTE by 6 months post-injury, prolonged video-EEG monitoring is crucial to identify animals with PTE. Our objective is to harmonize the surgical and data collection procedures, equipment, and data analysis for chronic EEG recording in order to phenotype PTE in this rat model across the three study sites. METHODS: Traumatic brain injury (TBI) was induced using lateral FPI in adult male Sprague-Dawley rats aged 11-12 weeks. Animals were divided into two cohorts: a) the long-term video-EEG follow-up cohort (Specific Aim 1), which was implanted with EEG electrodes within 24 h after the injury; and b) the magnetic resonance imaging (MRI) follow-up cohort (Specific Aim 2), at 5 months after lateral FPI. Four cortical epidural screw electrodes (2 ipsilateral, 2 contralateral) and three intracerebral bipolar electrodes were implanted (septal CA1 and the dentate gyrus, layers II and VI of the perilesional cortex both anterior and posterior to the injury site). During the 7th post-TBI month, animals underwent 4 weeks of continuous video-EEG recordings to diagnose of PTE. RESULTS: All centers harmonized the induction of TBI and surgical procedures for the implantation of EEG recordings, utilizing 4 or more EEG recording channels to cover areas ipsilateral and contralateral to the brain injury, perilesional cortex and the hippocampus and dentate gyrus. Ground and reference screw electrodes were implanted. At all sites the minimum sampling rate was 512 Hz, utilizing a finite impulse response (FIR) and impedance below 10 KΩ through the entire recording. As part of the quality control criteria we avoided electrical noise, and monitoring changes in impedance over time and the appearance of noise on the recordings. To reduce electrical noise, we regularly checked the integrity of the cables, stability of the EEG recording cap and the appropriate connection of the electrodes with the cables. Following the pipeline presented in this article and after applying the quality control criteria to our EEG recordings all of the sites were successful to phenotype seizure in chronic EEG recordings of animals after TBI. DISCUSSION: Despite differences in video-EEG acquisition equipment used, the three centers were able to consistently phenotype seizures in the lateral fluid-percussion model applying the pipeline presented here. The harmonization of methodology will help to improve the rigor of preclinical research, improving reproducibility of pre-clinical research in the search of biomarkers and therapies to prevent antiepileptogenesis.
RATIONALE: The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) Centre without walls is an NIH funded multicenter consortium. One of EpiBioS4Rx projects is a preclinical post-traumatic epileptogenesis biomarker study that involves three study sites: The University of Eastern Finland, Monash University (Melbourne) and the University of California Los Angeles. Our objective is to create a platform for evaluating biomarkers and testing new antiepileptogenic treatments for post-traumatic epilepsy (PTE) using the lateral fluid percussion injury (FPI) model in rats. As only 30-50% of rats with severe lateral FPI develop PTE by 6 months post-injury, prolonged video-EEG monitoring is crucial to identify animals with PTE. Our objective is to harmonize the surgical and data collection procedures, equipment, and data analysis for chronic EEG recording in order to phenotype PTE in this rat model across the three study sites. METHODS:Traumatic brain injury (TBI) was induced using lateral FPI in adult male Sprague-Dawley rats aged 11-12 weeks. Animals were divided into two cohorts: a) the long-term video-EEG follow-up cohort (Specific Aim 1), which was implanted with EEG electrodes within 24 h after the injury; and b) the magnetic resonance imaging (MRI) follow-up cohort (Specific Aim 2), at 5 months after lateral FPI. Four cortical epidural screw electrodes (2 ipsilateral, 2 contralateral) and three intracerebral bipolar electrodes were implanted (septal CA1 and the dentate gyrus, layers II and VI of the perilesional cortex both anterior and posterior to the injury site). During the 7th post-TBI month, animals underwent 4 weeks of continuous video-EEG recordings to diagnose of PTE. RESULTS: All centers harmonized the induction of TBI and surgical procedures for the implantation of EEG recordings, utilizing 4 or more EEG recording channels to cover areas ipsilateral and contralateral to the brain injury, perilesional cortex and the hippocampus and dentate gyrus. Ground and reference screw electrodes were implanted. At all sites the minimum sampling rate was 512 Hz, utilizing a finite impulse response (FIR) and impedance below 10 KΩ through the entire recording. As part of the quality control criteria we avoided electrical noise, and monitoring changes in impedance over time and the appearance of noise on the recordings. To reduce electrical noise, we regularly checked the integrity of the cables, stability of the EEG recording cap and the appropriate connection of the electrodes with the cables. Following the pipeline presented in this article and after applying the quality control criteria to our EEG recordings all of the sites were successful to phenotype seizure in chronic EEG recordings of animals after TBI. DISCUSSION: Despite differences in video-EEG acquisition equipment used, the three centers were able to consistently phenotype seizures in the lateral fluid-percussion model applying the pipeline presented here. The harmonization of methodology will help to improve the rigor of preclinical research, improving reproducibility of pre-clinical research in the search of biomarkers and therapies to prevent antiepileptogenesis.
Authors: Niina Lapinlampi; Esbjörn Melin; Eleonora Aronica; Jens P Bankstahl; Albert Becker; Cristophe Bernard; Jan A Gorter; Olli Gröhn; Anu Lipsanen; Katarzyna Lukasiuk; Wolfgang Löscher; Jussi Paananen; Teresa Ravizza; Paolo Roncon; Michele Simonato; Annamaria Vezzani; Merab Kokaia; Asla Pitkänen Journal: Epilepsy Res Date: 2016-11-22 Impact factor: 3.045
Authors: Amol M Bhandare; Komal Kapoor; Kim L Powell; Emma Braine; Pablo Casillas-Espinosa; Terence J O'Brien; Melissa M J Farnham; Paul M Pilowsky Journal: Neuroscience Date: 2017-03-18 Impact factor: 3.590
Authors: Rhys D Brady; Pablo M Casillas-Espinosa; Denes V Agoston; Edward H Bertram; Alaa Kamnaksh; Bridgette D Semple; Sandy R Shultz Journal: Neurobiol Dis Date: 2018-08-16 Impact factor: 5.996
Authors: Asla Pitkänen; Irina Kharatishvili; Heli Karhunen; Katarzyna Lukasiuk; Riikka Immonen; Jaak Nairismägi; Olli Gröhn; Jari Nissinen Journal: Epilepsia Date: 2007 Impact factor: 5.864
Authors: Jeffrey Englander; Tamara Bushnik; Thao T Duong; David X Cifu; Ross Zafonte; Jerry Wright; Richard Hughes; William Bergman Journal: Arch Phys Med Rehabil Date: 2003-03 Impact factor: 3.966
Authors: Pedro Andrade; Tomi Paananen; Robert Ciszek; Niina Lapinlampi; Asla Pitkänen Journal: J Neurosci Methods Date: 2018-06-21 Impact factor: 2.390
Authors: Rhys D Brady; Ker Rui Wong; Dale L Robinson; Richelle Mychasiuk; Stuart J McDonald; Ryan A D'Cunha; Glenn R Yamakawa; Mujun Sun; John D Wark; Peter Vee Sin Lee; Terence J O'Brien; Pablo M Casillas-Espinosa; Sandy R Shultz Journal: Front Pharmacol Date: 2019-10-29 Impact factor: 5.810